Rimonci Capital

Rimonci Capital is a venture capital firm investing within defined vertical sectors, with a notable focus on visual science.

Venture Capital Active Beijing, China Est. 2016
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
Seed, Pre-Seed, A Round

About

Rimonci Capital is a venture capital firm established in 2016, investing within defined vertical sectors. Its strategy employs a concentrated approach, notably with the Rimonci Global Vision Science Fund, emphasizing technological and scientific innovation. The firm identifies and supports companies in specialized industries, applying targeted expertise to accelerate development and market presence. Rimonci Capital supports emerging companies seeking strategic funding and guidance across its vertical markets, including Israeli investments. The firm's vision is to refine its specialized focus for a highly effective venture capital model, driving innovation and facilitating scalable expansion for promising enterprises.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

2 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences8

Funds · 1

  • Rimonci Star Venture Capital — $20M Jun 2021

Q&A

What is Rimonci Capital's primary investment focus?
Rimonci Capital focuses on visual science innovation, investing in early-stage companies in ophthalmology, optometry, and neuro-ophthalmology.
Which sectors does Rimonci Capital primarily invest in?
Rimonci Capital's portfolio shows a strong concentration in the Health Tech & Life Sciences sector, with all 8 of its listed portfolio companies falling into this category.
Can you name some of Rimonci Capital's notable exits?
Rimonci Capital has had two notable exits: BELKIN Vision was acquired by Alcon Pharmaceuticals for $81M in July 2024, and 6over6 was acquired by 1-800 Contacts for $100M in December 2019.
What investment stages does Rimonci Capital typically target?
Rimonci Capital primarily invests in Seed, Pre-Seed, and A Round stages.
Which fund has Rimonci Capital raised?
Rimonci Capital raised the Rimonci Star Venture Capital fund in June 2021.
Who are the key individuals at Rimonci Capital?
Richel Liu is the CEO and a founder of Rimonci Capital, and Limin Wang serves as the Regional General Manager.
Where is Rimonci Capital headquartered?
Rimonci Capital is headquartered in Beijing, China.
What is an example of a recent investment by Rimonci Capital?
Rimonci Capital invested in NovaSight, a company developing eye-tracking based solutions for pediatric vision care, which raised an A Round of $38.88M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)